Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 157

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 157
---
 White
Lion’s written confirmation of the acceptance of the Rapid Purchase Notice.

No purchase notice shall result
in White Lion beneficially owning (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended, and Rule
13d-3 thereunder) more than 4.99% (subject to increase, in the sole discretion of White Lion, to 9.99%) of the number of Class A Ordinary
Shares outstanding immediately prior to the issuance of Class A Ordinary Shares issuable pursuant to a purchase notice.

The Company has the right
to terminate the White Lion Purchase Agreement in the event of a material breach of the White Lion Purchase Agreement by White Lion. The
White Lion Purchase Agreement also automatically terminates upon the earlier of (i) the end of the Commitment Period and (ii) the date
that the Company commences a voluntary bankruptcy proceeding, a custodian is appointed for the Company or for all or substantially all
of its property, or the Company makes a general assignment for the benefit of its creditors.

In consideration for the commitments
of White Lion, as described above, the Company has agreed that it will issue to White Lion 700,000 Class A Ordinary Shares (“Commitment
Shares” and equivalent to 700 Post Third Reverse Stock Split). Additional Ordinary Shares may be issued to White Lion under certain
conditions, including in connection with material transactions or upon achieving specified investment thresholds. The Commitment Shares
will be fully earned by White Lion regardless of termination of the White Lion Purchase Agreement.

The White Lion Purchase Agreement
and the RRA contain customary representations, warranties, conditions and indemnification obligations of the parties. The representations,
warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely
for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

<div align='center'>92</div>

Business Model

With a focus on providing
fertility treatments to fulfil couples and individuals’ dreams of raising children, NewGenIvf offers mainly two services, namely:
(i) IVF treatment service, comprising traditional IVF and egg donation; and (ii) surrogacy and ancillary caring services. The
following table sets forth NewGenIvf’s revenue by service offerings and as a percentage of total revenue for the periods indicated:

|                                         |     | For the Year ended December 31, |      2024 |